Agricultural Inputs
Compare Stocks
4 / 10Stock Comparison
CTVA vs LIN vs APD vs FMC
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Agricultural Inputs
CTVA vs LIN vs APD vs FMC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Agricultural Inputs | Chemicals - Specialty | Chemicals - Specialty | Agricultural Inputs |
| Market Cap | $53.08B | $228.85B | $65.68B | $1.71B |
| Revenue (TTM) | $17.89B | $34.66B | $12.46B | $3.43B |
| Net Income (TTM) | $1.16B | $7.13B | $2.11B | $-2.50B |
| Gross Margin | 33.5% | 46.0% | 32.0% | 35.3% |
| Operating Margin | 13.8% | 28.8% | 18.4% | -59.5% |
| Forward P/E | 21.6x | 27.7x | 22.5x | 7.7x |
| Total Debt | $2.58B | $26.99B | $18.41B | $4.20B |
| Cash & Equiv. | $4.52B | $5.06B | $1.86B | $585M |
CTVA vs LIN vs APD vs FMC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Corteva, Inc. (CTVA) | 100 | 289.5 | +189.5% |
| Linde plc (LIN) | 100 | 244.1 | +144.1% |
| Air Products and Ch… (APD) | 100 | 122.1 | +22.1% |
| FMC Corporation (FMC) | 100 | 13.9 | -86.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTVA vs LIN vs APD vs FMC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTVA is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
- Beta 0.29, yield 0.9%, current ratio 1.43x
- +27.7% vs FMC's -57.1%
LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 375.2% 10Y total return vs CTVA's 186.7%
- PEG 1.09 vs CTVA's 1.81
- 3.0% revenue growth vs FMC's -18.3%
APD is the clearest fit if your priority is income & stability.
- Dividend streak 29 yrs, beta 0.45, yield 2.4%
FMC is the clearest fit if your priority is dividends.
- 17.0% yield, 7-year raise streak, vs APD's 2.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs FMC's -18.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.6% margin vs FMC's -72.9% | |
| Stability / Safety | Beta 0.24 vs FMC's 1.63, lower leverage | |
| Dividends | 17.0% yield, 7-year raise streak, vs APD's 2.4% | |
| Momentum (1Y) | +27.7% vs FMC's -57.1% | |
| Efficiency (ROA) | 8.3% ROA vs FMC's -23.0%, ROIC 11.3% vs -21.2% |
CTVA vs LIN vs APD vs FMC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CTVA vs LIN vs APD vs FMC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 2 of 6 categories
FMC leads 1 • CTVA leads 1 • APD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 10.1x FMC's $3.4B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to FMC's -72.9%. On growth, CTVA holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $17.9B | $34.7B | $12.5B | $3.4B |
| EBITDAEarnings before interest/tax | $3.4B | $12.1B | $3.9B | -$1.9B |
| Net IncomeAfter-tax profit | $1.2B | $7.1B | $2.1B | -$2.5B |
| Free Cash FlowCash after capex | $2.1B | $5.1B | $1.1B | -$91M |
| Gross MarginGross profit ÷ Revenue | +33.5% | +46.0% | +32.0% | +35.3% |
| Operating MarginEBIT ÷ Revenue | +13.8% | +28.8% | +18.4% | -59.5% |
| Net MarginNet income ÷ Revenue | +6.5% | +20.6% | +16.9% | -72.9% |
| FCF MarginFCF ÷ Revenue | +11.5% | +14.7% | +8.9% | -2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.0% | +8.2% | +8.8% | -4.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +12.6% | +13.4% | +141.1% | -17.8% |
Valuation Metrics
FMC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 33.8x trailing earnings, LIN trades at a 32% valuation discount to CTVA's 49.4x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.33x vs CTVA's 4.14x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $53.1B | $228.8B | $65.7B | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $51.1B | $250.8B | $82.2B | $5.3B |
| Trailing P/EPrice ÷ TTM EPS | 49.42x | 33.85x | -166.67x | -0.77x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.57x | 27.67x | 22.46x | 7.74x |
| PEG RatioP/E ÷ EPS growth rate | 4.14x | 1.33x | — | — |
| EV / EBITDAEnterprise value multiple | 13.38x | 19.75x | 119.66x | — |
| Price / SalesMarket cap ÷ Revenue | 3.05x | 6.73x | 5.46x | 0.49x |
| Price / BookPrice ÷ Book value/share | 2.18x | 5.82x | 3.79x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 18.86x | 44.97x | — | — |
Profitability & Efficiency
LIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-82 for FMC. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to FMC's 2.00x. On the Piotroski fundamental quality scale (0–9), CTVA scores 6/9 vs FMC's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +17.8% | +11.9% | -82.3% |
| ROA (TTM)Return on assets | +2.7% | +8.3% | +5.1% | -23.0% |
| ROICReturn on invested capital | +8.5% | +11.3% | -2.0% | -21.2% |
| ROCEReturn on capital employed | +8.6% | +13.0% | -2.4% | -25.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 2 | 2 |
| Debt / EquityFinancial leverage | 0.11x | 0.68x | 1.06x | 2.00x |
| Net DebtTotal debt minus cash | -$1.9B | $21.9B | $16.6B | $3.6B |
| Cash & Equiv.Liquid assets | $4.5B | $5.1B | $1.9B | $585M |
| Total DebtShort + long-term debt | $2.6B | $27.0B | $18.4B | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 5.82x | 34.52x | 12.00x | -0.24x |
Total Returns (Dividends Reinvested)
CTVA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,394 today (with dividends reinvested), compared to $1,983 for FMC. Over the past 12 months, CTVA leads with a +27.7% total return vs FMC's -57.1%. The 3-year compound annual growth rate (CAGR) favors CTVA at 12.1% vs FMC's -44.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +17.0% | +15.5% | +19.2% | -4.0% |
| 1-Year ReturnPast 12 months | +27.7% | +11.2% | +14.2% | -57.1% |
| 3-Year ReturnCumulative with dividends | +40.8% | +39.7% | +7.0% | -82.5% |
| 5-Year ReturnCumulative with dividends | +68.3% | +73.9% | +13.2% | -80.2% |
| 10-Year ReturnCumulative with dividends | +186.7% | +375.2% | +166.4% | -26.8% |
| CAGR (3Y)Annualised 3-year return | +12.1% | +11.8% | +2.3% | -44.0% |
Risk & Volatility
Evenly matched — LIN and APD each lead in 1 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than FMC's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APD currently trades 96.0% from its 52-week high vs FMC's 30.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | 0.24x | 0.45x | 1.63x |
| 52-Week HighHighest price in past year | $85.63 | $521.28 | $307.29 | $44.78 |
| 52-Week LowLowest price in past year | $60.54 | $387.78 | $229.11 | $12.17 |
| % of 52W HighCurrent price vs 52-week peak | +92.3% | +94.7% | +96.0% | +30.5% |
| RSI (14)Momentum oscillator 0–100 | 53.3 | 51.7 | 55.0 | 43.4 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 2.3M | 1.2M | 3.2M |
Analyst Outlook
Evenly matched — APD and FMC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTVA as "Buy", LIN as "Buy", APD as "Buy", FMC as "Hold". Consensus price targets imply 13.9% upside for FMC (target: $16) vs 6.0% for APD (target: $313). For income investors, FMC offers the higher dividend yield at 17.01% vs CTVA's 0.89%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $88.17 | $539.71 | $312.78 | $15.58 |
| # AnalystsCovering analysts | 37 | 28 | 42 | 42 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.2% | +2.4% | +17.0% |
| Dividend StreakConsecutive years of raises | 5 | 6 | 29 | 7 |
| Dividend / ShareAnnual DPS | $0.71 | $6.00 | $7.11 | $2.33 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +2.0% | 0.0% | +0.1% |
LIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FMC leads in 1 (Valuation Metrics). 2 tied.
CTVA vs LIN vs APD vs FMC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTVA or LIN or APD or FMC a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). Linde plc (LIN) offers the better valuation at 33. 8x trailing P/E (27. 7x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTVA or LIN or APD or FMC?
On trailing P/E, Linde plc (LIN) is the cheapest at 33.
8x versus Corteva, Inc. at 49. 4x. On forward P/E, FMC Corporation is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 09x versus Corteva, Inc. 's 1. 81x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CTVA or LIN or APD or FMC?
Over the past 5 years, Linde plc (LIN) delivered a total return of +73.
9%, compared to -80. 2% for FMC Corporation (FMC). Over 10 years, the gap is even starker: LIN returned +375. 2% versus FMC's -26. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTVA or LIN or APD or FMC?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus FMC Corporation's 1. 63β — meaning FMC is approximately 577% more volatile than LIN relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 2% for FMC Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CTVA or LIN or APD or FMC?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTVA or LIN or APD or FMC?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -64. 6% for FMC Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -54. 4% for FMC. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTVA or LIN or APD or FMC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 09x versus Corteva, Inc. 's 1. 81x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, FMC Corporation (FMC) trades at 7. 7x forward P/E versus 27. 7x for Linde plc — 19. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FMC: 13. 9% to $15. 58.
08Which pays a better dividend — CTVA or LIN or APD or FMC?
All stocks in this comparison pay dividends.
FMC Corporation (FMC) offers the highest yield at 17. 0%, versus 0. 9% for Corteva, Inc. (CTVA).
09Is CTVA or LIN or APD or FMC better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). FMC Corporation (FMC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, FMC: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTVA and LIN and APD and FMC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CTVA is a mid-cap quality compounder stock; LIN is a large-cap quality compounder stock; APD is a mid-cap quality compounder stock; FMC is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.